Educating Patients on Responsible Use of Weight Loss Drugs

The UK’s drug safety regulator is urging healthcare professionals to be vigilant about the misuse of obesity medications, amid growing concerns over patient misuse

CREDIT: This is an edited version of an article that originally appeared on the BBC

The UK’s drug safety regulator is urging doctors to remain vigilant for patients who may be misusing obesity injections, such as Wegovy. This call to action comes in response to reports of individuals who are not classified as obese experiencing adverse effects after using these medications for weight loss purposes. Common side effects associated with these injections include nausea, vomiting, bloating, constipation and diarrhoea.

While GPs are being called to be vigilant regarding the misuse of weight loss treatments, it is equally important for practice managers to facilitate this vigilance through clear and effective communication. Ensuring that all staff are informed about the risks associated with obesity injections and the importance of responsible prescribing practices is crucial in promoting patient safety.

Managing Misinformation

Given the rising popularity of weight loss drugs, partly fuelled by social media trends and influencer endorsements, practice managers must ensure that their staff are well-informed about the potential risks and warning signs of adverse reactions.

Misinformation surrounding these medications poses a significant challenge, as many individuals may seek advice from social media influencers instead of qualified medical professionals. This trend highlights the importance of educating both healthcare staff and patients about the responsible use of these medications.

Dispelling the Quick Fix Myth

Health Secretary Wes Streeting has emphasised the seriousness of these drugs, saying, “Weight-loss drugs have enormous potential. When taken alongside a healthy diet and exercise, they can be game changers in tackling obesity and helping people regain good health. However, these are not cosmetic drugs meant for achieving an idealised appearance for social media. These are serious medicines that should only be used responsibly and under medical supervision.”

Dr Alison Cave, MHRA Chief Safety Officer, said all medicines carry a risk of potential side-effects: “We encourage healthcare professionals to ensure patients being treated with these medicines are aware of the common side-effects and how to minimise risk.”

Practices must be proactive in how they communicate information regarding weight loss treatments. Clear messaging is essential to dispel misconceptions that these medications are a quick fix for weight loss or a means to achieve the ‘perfect’ body image portrayed on social media. In addition to providing accurate information, healthcare practices should actively signpost patients to reliable, evidence-based resources for weight management.

This includes directing them to registered dietitians, nutritionists and obesity specialists who can offer tailored advice and support.